CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 29.35 Min. order: 1 piece ★★★★★ 5.0 (227 reviews) Sold : Login>>
Cagrilintide and semaglutide act individually on both EI and EE a, US$ 25.69 Min. order: 1 piece ★★★★★ 4.4 (22 reviews) Sold : Login>>
NFL and NFLPA inform players of addition to banned substance list: BPC-157, an experimental peptide not approved for use by humans that has been found in supplements and recovery treatments US$ 24.81 Min. order: 1 piece ★★★★★ 4.9 (187 reviews) Sold : Login>>
BPC-157: Miracle Healing Peptide or Hidden Danger? US$ 23.87 Min. order: 1 piece ★★★★★ 4.9 (253 reviews) Sold : Login>>
Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review US$ 28.02 Min. order: 1 piece ★★★★★ 4.9 (53 reviews) Sold : Login>>